Screening Mammography: Getting to Version 2.0

Excerpt

In the last decade, screening mammography, long accepted as a significant advance in breast cancer care, has become a source of considerable controversy. Many factors have contributed to this shift, including reconsideration of the impact that routine screening has on mortality, concerns about overdiagnosis and overtreatment, and concerns about false-positive screens necessitating an invasive workup. The report by Elder and colleagues in this issue of Annals of Surgical Oncology adds to this debate by reminding us that more nuanced considerations to screening mammography beyond overdiagnosis and mortality exist, such as disease burden and treatment intensity, need to be considered. …